I would like to let @OP, @ecoool2, @wombat777 and @vinn decide between themselves, as The yankee is not in. My only concern is the actual production capacity. They need the product now. If approved, every hospital in US, at least, will scream for our cells. The rest will be history, with CHF, CLBP coming and AGVHD in the bag. I also see a big fight at the table between FDA, US gov, big pharma and MSB. They want at least a piece of action/ collaboration or a TO (I hope not under $100).
A Bigger Cash Cow for Revascor?, page-25
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.5¢ |
Change
-0.005(0.52%) |
Mkt cap ! $1.101B | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 99.5¢ | 96.0¢ | $2.283M | 2.340M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 29300 | 96.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |